News
AstraZenca’s antibody cocktail Evusheld receives MHRA authorisation
The Medicines & Healthcare products Regulatory Agency (MHRA) has authorised AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) – the first antibody combination for pre-exposure prophylaxis against COVID-19 licensed in the UK.